Trial Profile
Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Therapeutic Use
- 07 Dec 2015 New trial record